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24/41/80518 
Reply 
To the Editors: 
We appreciate the thoughtful and well-researched let- 
ter from Dr. Murphy. His reply is consistent with the 
outlook of most interventional radiologists as they report 
their experiences. 
A major point made by our report is that the format 
used by interventional r diologists i inconsistent with vas- 
cular surgical reporting standards. Dr. Murphy demon- 
strates the differing practices very well in his letter. For 
example, disputing the fact of an embolized stent as a 
complication is a clear deviation from vascular practice. 
Also, deployment of an additional $600 to $900 stent in 
the management ofhemodynamically significant iatrogenic 
dissections remote from or adjacent to the target lesion 
cannot be compared with placement of an additional su- 
ture in an anastomosis. In a recently presented update of 
our iliac stent experience, 1 we found the relative risk of a 
complication to be increased when multiple stents are used 
(relative risk, 2.65; p = 0.05) during the procedure. Fur- 
thermore, the relative risk of subsequent iliac artery throm- 
bosis was heavily influenced by the incidence of a proce- 
dure-related complication (relative risk, 15.33; p < 
0.0001). 
Dr. Murphy correctly makes the point that surgical 
intervention is more morbid than percutaneous angio- 
plasty. We have no disagreement with this fact and instead 
make a plea for uniform reporting of complications. As 
interventionalists and vascular surgeons work increasingly 
close together, it is crucial that they speak a common 
language~ Surgeons are trained to be meticulous in report- 
ing complications and in discussing them openly. Success- 
ful management of an untoward event as described by Dr. 
Murphy is a tribute to the skill of the interventional radiol- 
ogist but does not erase the fact of the complication. 
Lastly, although our experience demonstrates that outpa- 
tient iliac artery stent deployment can be done, that has not 
decreased our appreciation for the potential problems thac 
can occur with the procedure. 
As Dr. Murphy's letter provides trong evidence for 
the main point made in our article, we are grateful to him 
for taking the time to respond. 
Jeffrey L. Ballard, MD 
Division of Vascular Surgery 
Loma Linda Medical Center 
11234 Anderson St., Room 2586A 
Loma Linda, CA 92354 
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24/41/80519 
Regarding "Upper dorsal thoracoscopic 
sympathectomy for palmar hyperhidrosis: Improved 
intermediate-term results" 
To the Editors: 
Since 1990 we have performed more than 200 thora- 
coscopic sympathectomy procedures (in 100 patients) for 
palmar-axillary h perhidrosis or Raynaud's phenomenon. 
Contrary to the technique of Kopelman et al. (1996; 
24:194-9), we have always used double-lumen i tubation 
for ipsilateral lung collapse. Single-lumen intubation and 
CO2 insufflation entails the risk of tension pneumothorax 
and dramatic hemodynamic changes as a result of elevated 
intrathoracic pressures and is to be avoided, in our opinion. 
We have never seen postoperative atelectasis because 
we always ask the anesthesiologist to manually ventilate 
with positive end-expiratory pressure at the moment of 
instrument withdrawal. Only in one patient with bullous 
emphysema was postoperative thoracic drainage required, 
and all procedures were performed as planned. 
We operate with the patient in a semisupine position~, 
both sides consecutively, through two stab-wound inci- 
sions anterior on the chest in the second intercostal space. 
We are surprised by the high rate of complications (Hor- 
ner's syndrome, brachialgia) described by Dr. Kopelman et 
al., which we think are a result of.their surgical technique. 
We have always performed transpleural coagulation ofT2- 
T3-T4 ganglia, avoiding any dissection of or traction on 
the sympathetic chain. Performing this technique, we have 
